Ursodeoxycholic acid (sodium) - HY-13771A
Nur noch %1 verfügbar
Catalog #
HY-13771A
Ab
26,00 €
Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid sodium can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-13771A/Ursodeoxycholic-acid-sodium-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Metabolism-sugar/lipid metabolism |
| Alternative Names | Ursodeoxycholate (sodium); Ursodiol (sodium); UCDA (sodium) |
| CAS | 2898-95-5 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 414.55 |
| Solubility | DMSO : 125 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : ≥ 100 mg/mL |
| Clinical Information | Launched |
| Target | Endogenous Metabolite;FXR;G protein-coupled Bile Acid Receptor 1 |
| Application: | Metabolism-sugar/lipid metabolism |
|---|